F026 Dermatopathology Case Challenge: Recognizing Mimics and Masqueraders
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Mimics in dermatology and dermatopathology pose a potential pitfall in the accurate diagnosis. This session intends to provide dermatopathologists, dermatologists, and those in training with enhanced awareness of both common and novel mimics that may be encountered in dermatopathology practice. An interactive case-based format will be utilized, and speakers will describe masqueraders that they have faced, ancillary tools employed, and the lessons learned in reaching the correct interpretation. Dermatopathologists and dermatologists may not readily recognize entities that can serve as mimics. This may result in unintentional diagnostic errors and delay of appropriate patient treatment.
LEARNING OBJECTIVES
Identify diagnostic entities that present as mimics in dermatopathology.
Recognize clinical and histopathologic features that can help avoid diagnostic pitfalls when faced with a dermatopathologic mimic.
Utilize ancillary tests when appropriate to enhance diagnostic accuracy in challenging dermatopathologic cases.
SPEAKERS
Soon Bahrami, MD
Rosalie Elenitsas, MD, FAAD
Carly Elston, MD, FAAD
Dirk Michael Elston, MD, FAAD
Tammie C. Ferringer, MD, FAAD
Alexandra Flamm, MD, FAAD
Kevin John Gaddis, MD, FAAD
Ronald P Rapini, MD, FAAD
Michi Shinohara, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Soon Bahrami, MD
No financial relationships exist with ineligible companies.
Rosalie Elenitsas, MD, FAAD
No financial relationships exist with ineligible companies.
Carly Elston, MD, FAAD
No financial relationships exist with ineligible companies.
Dirk Michael Elston, MD, FAAD
No financial relationships exist with ineligible companies.
Tammie C. Ferringer, MD, FAAD
No financial relationships exist with ineligible companies.
Alexandra Flamm, MD, FAAD
No financial relationships exist with ineligible companies.
Kevin John Gaddis, MD, FAAD
No financial relationships exist with ineligible companies.
Ronald P Rapini, MD, FAAD
No financial relationships exist with ineligible companies.
Michi Shinohara, MD, FAAD
Kyowa Hakko Kirin Pharma, Inc. – Consultant (1099 relationship)(Fees); Kyowa Kirin – Investigator(Grants/Research Funding);